Effects of Green Light Therapy on Body Contouring and Cellulite

Launched by WARD PHOTONICS LLC · Aug 23, 2018

Keywords

ClinConnect Summary

This clinical trial will provide objective evidence showing effectiveness of the Cellulize 532nm green light therapy for the non-invasive reduction in fat layer for body contouring, and for the non-invasive treatment for the appearance of cellulite.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Study participant between the ages of 18 and older.
• • Female only
• • Subject is willing and able to abstain from partaking in any treatment other than the study procedures (existing or new) to promote body contouring/circumference reduction/weight loss during the course of study participation.
• • Subject is willing and able to maintain his or her regular (typical pre-study) diet and exercise regimen without effecting significant change in either direction during study participation.
• Exclusion Criteria:
• • No photo-therapy (red or green) within 3 weeks of treatment.
• • Known cardiovascular disease such as cardiac arrhythmias, congestive heart failure.
• • Cardiac surgeries such as cardiac bypass, heart transplant surgery, pacemakers.
• • Prior surgical intervention for body sculpting/weight loss, such as liposuction, abdominoplasty, stomach stapling, lap band surgery, etc.
• • Medical, physical, or other contraindications for body sculpting/weight loss.
• • Current use of medication(s) known to affect weight levels/cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent.
• • Any medical condition known to affect weight levels and/or to cause bloating or swelling.
• • Active infection, open wound (e.g. sores, cuts, ulcers, burns, etc.) or other external trauma to the areas to be treated with the laser/lymphatic drainage system devices.
• • Photosensitive condition or medication.
• • Active cancer within the past year.
• • Pregnant, possibly pregnant or planning pregnancy prior to the end of study participation.
• • Diminished ability to void waste (liver or kidneys).
• • Developmental disability or cognitive impairment that in the opinion of the investigator would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements.